{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:36:30Z","timestamp":1787150190221,"version":"build-2736575974"},"reference-count":41,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Patient Care and STDs"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:p>The Rio Grande Valley (RGV) comprises counties with some of the highest prevalence of HIV in Texas. The predominantly Latino population also faces socioeconomic challenges, including high poverty rates, low health literacy, and transiency, contributing to increased risk of advanced HIV disease. AHORA was a real-world mixed-methods study evaluating viral control and immune reconstitution in a Latino population with advanced HIV disease, who were enrolled in a rapid start treatment program with bictegravir\/emtricitabine\/tenofovir alafenamide (B\/F\/TAF) at two clinics in the RGV. To explore reasons for late diagnosis and experiences of rapid antiretroviral therapy (ART) initiation, document analysis and 27 in-depth semi-structured interviews were conducted with 18 individuals receiving treatment and 9 clinic staff. Median time to an HIV-1 RNA level &lt;200 copies\/mL was 5.3 weeks, with 90.5% (19\/21) achieving this by Week 24. There were statistically significant differences in mean HIV-1 RNA levels, CD4% and CD4 counts between baseline and Week 24. Strategies to maximize ART engagement were grounded in person-centered care and included regular appointment reminders and transportation assistance. Common barriers to accessing care included limited HIV knowledge and financial constraints. These were addressed through education and financial support, including the provision of treatment samples at no cost, independent of insurance status. The AHORA study effectively showcases the benefits of rapid B\/F\/TAF initiation for individuals with advanced HIV in the RGV, facilitating early viral suppression and improved health outcomes. It also emphasizes the critical role of person-centered care and tailored support services in overcoming health care access barriers.<\/jats:p>","DOI":"10.1177\/10872914251379972","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:00:17Z","timestamp":1759240817000},"page":"427-440","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The AHORA Study: A Real-World Mixed-Methods Study Investigating the Effectiveness of, and Experiences with, Rapid Antiretroviral Therapy Initiation in People with Advanced HIV in the Rio Grande Valley, Texas"],"prefix":"10.1177","volume":"39","author":[{"given":"Linda","family":"Mercado","sequence":"first","affiliation":[{"name":"Valley AIDS Council, Harlingen, Texas, USA."},{"name":"Valley AIDS Council, McAllen, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Quiroga","sequence":"additional","affiliation":[{"name":"Valley AIDS Council, Harlingen, Texas, USA."},{"name":"Valley AIDS Council, McAllen, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Cantu","sequence":"additional","affiliation":[{"name":"Valley AIDS Council, Harlingen, Texas, USA."},{"name":"Valley AIDS Council, McAllen, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mena","sequence":"additional","affiliation":[{"name":"Valley AIDS Council, Harlingen, Texas, USA."},{"name":"Valley AIDS Council, McAllen, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Francis-Graham","sequence":"additional","affiliation":[{"name":"Costello Medical, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Costello","sequence":"additional","affiliation":[{"name":"Costello Medical, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Costello Medical, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Borda","sequence":"additional","affiliation":[{"name":"Costello Medical, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Ng","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"McCoy","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"Diagnoses, deaths, and prevalence of HIV in the United States and 6 territories and freely associated states, 2022","author":"Centers for Disease Control and Prevention","year":"2024","unstructured":"Centers for Disease Control and Prevention. Diagnoses, deaths, and prevalence of HIV in the United States and 6 territories and freely associated states, 2022. Centers for Disease Control and Prevention: 2024."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305309"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2406595"},{"key":"e_1_3_3_5_2","unstructured":"Centers for Disease Control and Prevention. HIV diagnoses | 2023 | Ages 13 years and older | All races\/ethnicities | Both sexes | All transmission categories | US Map-State Level. Available from: https:\/\/gis.cdc.gov\/grasp\/nchhstpatlas\/main.html [Last accessed: January8 2025]."},{"key":"e_1_3_3_6_2","unstructured":"Centers for Disease Control and Prevention. HIV diagnoses | 2022 | Ages 13 years and older | All races\/ethnicities | Both sexes | All transmission categories | Texas-County Level. Available from: https:\/\/gis.cdc.gov\/grasp\/nchhstpatlas\/maps.html [Last accessed: January17 2025]."},{"key":"e_1_3_3_7_2","unstructured":"Unidos Contra la Diabetes. Rio Grande Valley 2023 Demographics. 2023. Available from: https:\/\/www.rgvhealthconnect.org\/index.php?module=DemographicData&controller=index&action=index [Last accessed: December12 2023]."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162x17666191029162235"},{"key":"e_1_3_3_9_2","unstructured":"Services TDoSH. Texas HIV Surveillance Report. 2022."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1213"},{"key":"e_1_3_3_11_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000002979"},{"key":"e_1_3_3_13_2","volume-title":"WHO guidelines approved by the guidelines review committee","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. WHO guidelines approved by the guidelines review committee. World Health Organization: Geneva; 2017."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.8431"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002357"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002015"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000002124"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy104"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09500-w"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/13691058.2014.886131"},{"key":"e_1_3_3_21_2","volume-title":"Designing and Conducting Mixed-Methods Research","author":"Creswell JW","year":"2018","unstructured":"Creswell JW, , Plano Clark VL. Designing and Conducting Mixed-Methods Research. SAGE Publications Inc.: 2018."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/1356389016638615"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1609406919899220"},{"key":"e_1_3_3_26_2","author":"Miles M","year":"1994","unstructured":"Miles M, , Huberman A. Qualitative data analysis: An expanded sourcebook. SAGE: London; 1994.","journal-title":"Qualitative data analysis: An expanded sourcebook"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/2325958220936014"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-012-9714-3"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/hs.2021.0005"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001285"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.70065"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2025.01011"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab469"},{"key":"e_1_3_3_34_2","unstructured":"The National Institutes of Health. The stages of HIV infection. 2021. Available from: https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/stages-hiv-infection#:\u223c:text=partner%20through%20sex.- AIDS typically%20survive%20about%203%20years"},{"key":"e_1_3_3_35_2","volume-title":"StatPearls. StatPearls Publishing Copyright \u00a9 2025","author":"Battistini Garcia SA","year":"2025","unstructured":"Battistini Garcia SA, , Zubair M, , Guzman N. Acquired Immune Deficiency Syndrome CD4+ count. In: StatPearls. StatPearls Publishing Copyright \u00a9 2025. StatPearls Publishing LLC.: Treasure Island, FL; 2025."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00215"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2023.0173"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2166-6"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/ms9.0000000000002976"},{"key":"e_1_3_3_40_2","unstructured":"KFF. The Ryan White HIV\/AIDS Program: The Basics. 2025. Available from: https:\/\/www.kff.org\/hivaids\/fact-sheet\/the-ryan-white-hiv-aids-program-the-basics\/ [Last accessed: August12 2025]."},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep14543"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/1468794115626244"}],"container-title":["AIDS Patient Care and STDs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10872914251379972","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10872914251379972","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10872914251379972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:23:05Z","timestamp":1787149385000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10872914251379972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"alternative-id":["10.1177\/10872914251379972"],"URL":"https:\/\/doi.org\/10.1177\/10872914251379972","relation":{},"ISSN":["1087-2914","1557-7449"],"issn-type":[{"value":"1087-2914","type":"print"},{"value":"1557-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}